Kinnevik | Latest News & Updates - Oct 17, 2024 Release

Kinnevik increased its stake in Spring Health from 12% to 15%...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Kinnevik

🌎 kinnevik.com

Kinnevik is a venture capital investment firm based in Stockholm, Sweden, founded in 1936. The company focuses on being a leading growth investor in Europe, particularly in digital consumer businesses across sectors such as healthcare, software, marketplaces, and climate tech. Kinnevik aims to support challenger companies at various stages of their development, leveraging its nearly 100-year legacy of investing expertise to deliver significant returns while promoting sustainable business models and diverse teams.


Kinnevik - Latest News and Updates

  • Kinnevik increased its stake in Spring Health from 12% to 15%.
  • Kinnevik invested more capital in Aira alongside co-investors Temasek and Altor, scaling Aira's annualized sales to EUR 100 million as of Q3 2024.
  • Kinnevik has written off its 3% stake in VillageMD, previously valued at SEK1.1bn, due to uncertainty about the company's future.
  • Kinnevik's Q3 2024 results show a completed transformation to growth, with investments in Spring Health and Aira, but a full write-down of VillageMD impacted their Net Asset Value.
  • Kinnevik completed its transformation to a growth-focused portfolio and divested Tele2, resulting in a strong financial position with a net cash of SEK 12.2bn, as reported by CEO Georgi Ganev.
  • Kinnevik recently devalued its 21% share in Monese following HSBC's write-off of its stake.
  • Kinnevik's Venture and Growth Investor Ala Alenazi discussed the future of quantum and AI at an event hosted by the Lord Mayor of the City of London, focusing on quantum modelling's potential to transform health.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.